Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

FDA yanks anti-nausea drug due to arrhythmia risks

The FDA is notifying healthcare professionals, particularly surgery and oncology specialists, that the 32 mg, single intravenous (IV) dose of the anti-nausea drug ondansetron hydrochloride (Zofran, GlaxoSmithKline) will no longer be marketed because of the potential for serious cardiac risks.

Volcano delves into PE market with nearly $40M buy of Crux

Volcano, a developer and manufacturer of tools for the diagnosis and treatment of coronary and peripheral vascular disease, has signed an agreement to acquire Crux Biomedical, a privately held company that has developed an inferior vena cava filter—the Crux VCF System—to treat pulmonary embolisms (PEs).

SCAI consensus statement advises more consideration before ad hoc PCI

The Society for Cardiovascular Angiography and Interventions (SCAI) issued a consensus statement Nov. 29 updating recommendations about appropriate use of ad hoc PCI, or PCI performed at the same time as a diagnostic coronary angiography.

Baxter expands dialysis line with $4B purchase of Gambro

Baxter International has entered into a definitive agreement to acquire Gambro, a privately held dialysis product company based in Lund, Sweden, for total consideration of 26.5 billion SEK, or approximately $4 billion U.S. at current exchange rates.

Warfarin risk highest in first 30 days of therapy

Hemorrhage rates in older atrial fibrillation (AF) patients exceed those reported in clinical trials, according to a study published online Nov. 26 in the Canadian Medical Association Journal, and risks are especially high during the first 30-days of treatment.

Score helps docs assess CAS risk in high-risk patients

It is possible to analyze a number of commonly collected variables and use them to quantify the possibility that patients who present a high risk of surgical complications will experience death or stroke within 30 days of endovascular carotid artery stenting (CAS), concludes a study published in the December issue of Stroke.

Medtronic’s Q2 earnings drop 26%

Medtronic has announced a drop in net earnings for its second quarter of fiscal year 2013, which ended Oct. 26, despite a slight increase in sales.

Abbott's board approves pharma split

Abbott’s board of directors has approved the separation of its research-based pharmaceuticals business, which will be known as AbbVie, and declared a special dividend distribution of all of the outstanding shares of AbbVie common stock.

Displaying 8473 - 8480 of 10761

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.